Several clinical trials and experimental studies strongly suggest a place for Saccharomyces
boulardii as a biotherapeutic agent for the prevention and treatment of several …

As locomotive organelles, flagella allow bacteria to move toward favorable environments. A
flagellum consists of three parts: the basal structure (rotary motor), the hook (universal joint) …

Increased numbers of mucosa-associated Escherichia coli are observed in both major
inflammatory bowel diseases, Crohn's disease (CD) and ulcerative colitis (UC). With the …

Enterohemorrhagic Escherichia coli O157: H7 (EHEC) is an enteric pathogen that causes
potentially fatal symptoms after intimate adhesion, modulation of intestinal epithelial signal …

The probiotic potential of 18 Saccharomyces cerevisiae strains used for production of foods
or beverages or isolated from such, and eight strains of Saccharomyces cerevisiae var …

Aliment Pharmacol Ther 30, 826–833 Summary Background Saccharomyces boulardii, a
well‐studied probiotic, can be effective in inflammatory gastrointestinal diseases with …

Enterohemorrhagic Escherichia coli (EHEC) infections are associated with the modification
of tight-junction permeability and synthesis of proinflammatory cytokine interleukin-8 (IL-8) …

Summary Enterohaemorrhagic Escherichia coli (EHEC) O157: H7 uses a specialized
protein translocation apparatus, the type III secretion system (TTSS), to deliver bacterial …

Shiga toxins (Stxs), syn. Vero (cyto) toxins, are potent bacterial exotoxins and the principal
virulence factor of enterohemorrhagic Escherichia coli (EHEC), a subset of Shiga toxin …

Blastocystis is a ubiquitous enteric protozoan found in the intestinal tracts of humans and a
wide range of animals. Evidence accumulated over the last decade suggests association of …